However, at high concentrations or within specific tumor microenvironments, IAA may excessively activate AhR, skewing toward immunosuppressive networks and attenuating CD8+ T-cell effector function, ultimately diminishing the efficacy of PD-1/PD-L1 blockade (179). This evidence concerns the gene CD8A and neoplasm.